IL6 and neoplasm: Moreover, all recruited patients had a late-stage disease and therefore it is possible that the anti-metastatic effects of IL-6/IL-6R blockade would be stronger in combination with a cytotoxic therapy such as chemotherapy, to prevent the outgrowth of new metastatic lesions following chemotherapy-induced tumour regression.